Literature DB >> 20054657

A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma.

Fatemeh Abbaszadeh1, Karen T Barker, Carmel McConville, Richard H Scott, Nazneen Rahman.   

Abstract

Wilms tumor and neuroblastoma are childhood tumors of the kidney and undifferentiated neural crest cells, respectively. Both disorders are primarily sporadic, but familial Wilms tumor pedigrees and familial neuroblastoma pedigrees are each well recognized and account for approximately 1-3% of each tumor type. Families with Wilms tumor and neuroblastoma in the same, or related individuals, have not been reported. Here, we present nine families with two or more individuals with Wilms tumor and/or neuroblastoma. The affected individuals were otherwise well, without syndromic features. Although this co-occurrence might be due to chance in some families, the coexistence of two rare embryonal tumors in related individuals of multiple families suggests an underlying genetic susceptibility to both tumors. We undertook mutational analysis of the genes known to predispose to non-syndromic familial Wilms tumor (WT1) or neuroblastoma (PHOX2B, ALK) which excluded these as the underlying predisposition genes in the nine families. We also excluded epigenetic and copy-number abnormalities at 11p15 which are known to predispose to embryonal tumors including Wilms tumor and neuroblastoma. Overall, these data suggest that families with both Wilms tumor and neuroblastoma represent a previously unrecognized familial cancer syndrome in which the underlying predisposition gene(s) remain to be determined.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20054657     DOI: 10.1007/s10689-009-9319-8

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  24 in total

1.  Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21.

Authors:  N Rahman; L Arbour; P Tonin; J Renshaw; J Pelletier; S Baruchel; K Pritchard-Jones; M R Stratton; S A Narod
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

Review 2.  Should chromosome breakage studies be performed in patients with VACTERL association?

Authors:  Laurence Faivre; Marie France Portnoï; Gerard Pals; Dominique Stoppa-Lyonnet; Martine Le Merrer; Christel Thauvin-Robinet; Frédéric Huet; Christopher G Mathew; Hans Joenje; Alain Verloes; Clarisse Baumann
Journal:  Am J Med Genet A       Date:  2005-08-15       Impact factor: 2.802

3.  The International Neuroblastoma Pathology Classification (the Shimada system).

Authors:  H Shimada; I M Ambros; L P Dehner; J Hata; V V Joshi; B Roald; D O Stram; R B Gerbing; J N Lukens; K K Matthay; R P Castleberry
Journal:  Cancer       Date:  1999-07-15       Impact factor: 6.860

4.  Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry.

Authors:  M R DeBaun; M A Tucker
Journal:  J Pediatr       Date:  1998-03       Impact factor: 4.406

5.  PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations.

Authors:  Carmel McConville; Sarah Reid; Linda Baskcomb; Jenny Douglas; Nazneen Rahman
Journal:  Am J Med Genet A       Date:  2006-06-15       Impact factor: 2.802

6.  The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.

Authors:  Susan L Cohn; Andrew D J Pearson; Wendy B London; Tom Monclair; Peter F Ambros; Garrett M Brodeur; Andreas Faldum; Barbara Hero; Tomoko Iehara; David Machin; Veronique Mosseri; Thorsten Simon; Alberto Garaventa; Victoria Castel; Katherine K Matthay
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

Review 7.  Mechanisms predisposing to childhood overgrowth and cancer.

Authors:  Nazneen Rahman
Journal:  Curr Opin Genet Dev       Date:  2005-06       Impact factor: 5.578

8.  Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations.

Authors:  Katrina Tatton-Brown; Jenny Douglas; Kim Coleman; Genevieve Baujat; Trevor R P Cole; Soma Das; Denise Horn; Helen E Hughes; I Karen Temple; Francesca Faravelli; Darrel Waggoner; Seval Turkmen; Valerie Cormier-Daire; Alexandre Irrthum; Nazneen Rahman
Journal:  Am J Hum Genet       Date:  2005-06-07       Impact factor: 11.025

9.  International variations in the incidence of childhood renal tumours.

Authors:  C A Stiller; D M Parkin
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

10.  Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor.

Authors:  Richard H Scott; Jenny Douglas; Linda Baskcomb; Nikki Huxter; Karen Barker; Sandra Hanks; Alan Craft; Mary Gerrard; Janice A Kohler; Gill A Levitt; Sue Picton; Barry Pizer; Milind D Ronghe; Denise Williams; Jackie A Cook; Pascal Pujol; Eamonn R Maher; Jillian M Birch; Charles A Stiller; Kathy Pritchard-Jones; Nazneen Rahman
Journal:  Nat Genet       Date:  2008-10-05       Impact factor: 38.330

View more
  1 in total

1.  ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome.

Authors:  Franck Bourdeaut; Sandrine Ferrand; Laurence Brugières; Marjorie Hilbert; Agnès Ribeiro; Ludovic Lacroix; Jean Bénard; Valérie Combaret; Jean Michon; Dominique Valteau-Couanet; Bertrand Isidor; Xavier Rialland; Maryline Poirée; Anne-Sophie Defachelles; Michel Peuchmaur; Gudrun Schleiermacher; Gaëlle Pierron; Marion Gauthier-Villars; Isabelle Janoueix-Lerosey; Olivier Delattre
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.